Cookie Settings
We use cookies to provide the best possible website experience for you. This includes cookies that are technically required to ensure a proper functioning of the website, as well as cookies which are used solely for anonymous statistical purposes, for more comfortable website settings, or for displaying personalized content. You are free to choose the categories you would like to permit. Please note that depending on your settings, the full functionality of the website may no longer be available. Further information can be found in our Privacy Statement and Cookie Statement.
Separation of CD3 + cells from human PBMCs using a biotinylated CD3 antibody, Anti-Biotin MicroBeads, and an MS Column. |
PBMCs before separation | CD3 - cells |
Anti-Biotin MicroBeadsFigure 1Separation of CD3 + cells from human PBMCs using a biotinylated CD3 antibody, Anti-Biotin MicroBeads, and an MS Column. | Anti-Biotin MicroBeadsFigure 1Separation of CD3 + cells from human PBMCs using a biotinylated CD3 antibody, Anti-Biotin MicroBeads, and an MS Column. |
CD3 + cells | |
Anti-Biotin MicroBeadsFigure 1Separation of CD3 + cells from human PBMCs using a biotinylated CD3 antibody, Anti-Biotin MicroBeads, and an MS Column. |
Human CLEC9a + cells were isolated from a debris-rich sample of peripheral blood mononuclear cells (PBMCs) using Anti-CLEC9a- Biotin, Anti-Biotin MicroBeads UltraPure, two MS Columns, and a MiniMACS™ Separator. Cells were stained with Anti-Biotin-PE (# 130-090-756), CD141 (BDCA-3)-APC (# 130-090-907), and Propidium Iodide Solution (# 130-093-233). Cells were analyzed after gating on viable lymphoid cells. |
Before separation | After separation |
Anti-Biotin MicroBeadsFigure 2Human CLEC9a + cells were isolated from a debris-rich sample of peripheral blood mononuclear cells (PBMCs) using Anti-CLEC9a- Biotin, Anti-Biotin MicroBeads UltraPure, two MS Columns, and a MiniMACS™ Separator. Cells were stained with Anti-Biotin-PE (# 130-090-756), CD141 (BDCA-3)-APC (# 130-090-907), and Propidium Iodide Solution (# 130-093-233). Cells were analyzed after gating on viable lymphoid cells. | Anti-Biotin MicroBeadsFigure 2Human CLEC9a + cells were isolated from a debris-rich sample of peripheral blood mononuclear cells (PBMCs) using Anti-CLEC9a- Biotin, Anti-Biotin MicroBeads UltraPure, two MS Columns, and a MiniMACS™ Separator. Cells were stained with Anti-Biotin-PE (# 130-090-756), CD141 (BDCA-3)-APC (# 130-090-907), and Propidium Iodide Solution (# 130-093-233). Cells were analyzed after gating on viable lymphoid cells. |
Separation of CD3 + cells from human PBMCs using a biotinylated CD3 antibody, Anti-Biotin MicroBeads, and an MS Column. |
PBMCs before separation | CD3 - cells |
Anti-Biotin MicroBeadsFigure 1Separation of CD3 + cells from human PBMCs using a biotinylated CD3 antibody, Anti-Biotin MicroBeads, and an MS Column. | Anti-Biotin MicroBeadsFigure 1Separation of CD3 + cells from human PBMCs using a biotinylated CD3 antibody, Anti-Biotin MicroBeads, and an MS Column. |
CD3 + cells | |
Anti-Biotin MicroBeadsFigure 1Separation of CD3 + cells from human PBMCs using a biotinylated CD3 antibody, Anti-Biotin MicroBeads, and an MS Column. |
Human CLEC9a + cells were isolated from a debris-rich sample of peripheral blood mononuclear cells (PBMCs) using Anti-CLEC9a- Biotin, Anti-Biotin MicroBeads UltraPure, two MS Columns, and a MiniMACS™ Separator. Cells were stained with Anti-Biotin-PE (# 130-090-756), CD141 (BDCA-3)-APC (# 130-090-907), and Propidium Iodide Solution (# 130-093-233). Cells were analyzed after gating on viable lymphoid cells. |
Before separation | After separation |
Anti-Biotin MicroBeadsFigure 2Human CLEC9a + cells were isolated from a debris-rich sample of peripheral blood mononuclear cells (PBMCs) using Anti-CLEC9a- Biotin, Anti-Biotin MicroBeads UltraPure, two MS Columns, and a MiniMACS™ Separator. Cells were stained with Anti-Biotin-PE (# 130-090-756), CD141 (BDCA-3)-APC (# 130-090-907), and Propidium Iodide Solution (# 130-093-233). Cells were analyzed after gating on viable lymphoid cells. | Anti-Biotin MicroBeadsFigure 2Human CLEC9a + cells were isolated from a debris-rich sample of peripheral blood mononuclear cells (PBMCs) using Anti-CLEC9a- Biotin, Anti-Biotin MicroBeads UltraPure, two MS Columns, and a MiniMACS™ Separator. Cells were stained with Anti-Biotin-PE (# 130-090-756), CD141 (BDCA-3)-APC (# 130-090-907), and Propidium Iodide Solution (# 130-093-233). Cells were analyzed after gating on viable lymphoid cells. |
Seems like you are coming from USA!
Do you want to visit our website in your country?
Copyright © 2023 Miltenyi Biotec and/or its affiliates. All rights reserved.